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Escherichia coli isolates from patients with bacteriuria of pregnancy were compared by PCR with isolates
from patients with community-acquired cystitis for the presence of established virulence determinants. The
strains from patients with bacteriuria of pregnancy were less likely to carry genes for P-family, S-family, and
F1C adhesins, cytotoxic necrotizing factor 1, and aerobactin, but virtually all of the strains carried the genes
for type 1 fimbriae. Standard mannose-sensitive agglutination of yeast cells showed that only 15 of 42
bacteriuria strains (36%) expressed type 1 fimbriae compared with 32 of 42 strains from community-acquired
symptomatic infections (76%) (P < 0.01). This difference was confirmed by analysis of all isolates for an allele
of the type 1 fimbrial regulatory region (fim switch), which negates type 1 fimbrial expression by preventing the
fim switch from being inverted to the on phase. This allele, fimS49, was found in 8 of 47 bacteriuria strains from
pregnant women (17.0%) compared with 2 of 60 strains isolated from patients with cystitis (3.3%) (P < 0.05).
Determination of the phase switch orientation in vivo by analysis of freshly collected infected urine from
patients with bacteriuria showed that the fim switch was detectable in the off orientation in 17 of 23 urine
samples analyzed (74%). These data indicate that type 1 fimbriae are not necessary to maintain the majority
of E. coli bacteriurias in pregnant women since there appears to be selection against their expression in this
particular group. This is in contrast to the considered role of this adhesin in community-acquired symptomatic
infections. The lack of type 1 fimbria expression is likely to contribute to the asymptomatic nature of
bacteriuria in pregnant women, although approximately one-third of the bacteriuria isolates do possess key
virulence determinants. If left untreated, this subset of isolates pose the greatest threat to the health of the
mother and unborn child.
Escherichia coli, the most common cause of bacteriuria, is
usually able to express a number of adherence factors that
promote initial colonization and allow persistence in the face
of regular urine flow (4, 31, 32). The most common E. coli
adhesin, expressed by over 80% of uropathogenic strains, is the
type 1 fimbria. Type 1 fimbriae are long, thin proteinaceous
surface organelles with a tip composed of the FimH protein
that binds to a-D-mannose-containing receptors (18, 28). Uro-
plakins appear to be a receptor for type 1 fimbriae within the
bladder and associated tissue (33). Expression of type 1 fim-
briae has been shown to occur in vivo and to be important for
initiation of urinary tract infections (UTIs) (3, 4, 27). The
urinary tract has a number of mechanisms to prevent coloni-
zation by bacteria, including an immune response to antigenic
fimbriae and mucus to act as a barrier to adherence. To evade
this immune response and to save the potential metabolic
burden of producing fimbriae, E. coli has evolved complex
phase-variable mechanisms to regulate expression of most ad-
hesins. For type 1 fimbriae, the fim promoter is located on a
314-bp “switch” region of the chromosome flanked by inverted
repeats (1). In a now well-characterized process, the switch
region can be inverted from off to on and vice versa by two
recombinases (FimB and FimE) so that the promoter is either
correctly or incorrectly oriented to produce type 1 fimbriae (7,
17, 24). We have previously analyzed the switch region of E.
coli strains isolated from UTIs and shown that functional het-
erogeneity exists in the regulation of type 1 phase switching.
While the majority of strains could produce type 1 fimbriae
under favorable conditions, some strains had the switch locked
in the off orientation. One allele (fimS49, screened for in the
present study) was isolated which had a single-base-pair inser-
tion in one of the recombinase binding sites, practically pre-
venting phase transition to the on state (20). UTIs occur in 2 to
10% of pregnant women. During the first trimester they are
often asymptomatic, and approximately one-third of affected
women will develop pyelonephritis if left untreated (15, 16,
22). Asymptomatic bacteriuria (ASB) is also associated with
low birth weight, prematurity, hypertension, preeclampsia, ma-
ternal anemia, amnionitis, and fetal death (2). Treatment of
ASB can reduce these risks, and therefore all women attending
the antenatal clinic at the Royal Victoria Infirmary, Newcastle
upon Tyne, United Kingdom, are screened for ASB by urine
culture. All positive culture results are followed up in the
bacteriuria clinic, where a fresh sample is obtained from the
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patient to confirm that an infection is present and appropriate
antimicrobial therapy is prescribed when culture results be-
come available. ASB in nonpregnant women is usually uncom-
plicated and self-limiting.
The bacterial factors that may contribute to asymptomatic
infection are not clear. Many bacterial surface and secreted
components such as fimbriae and toxins can stimulate inflam-
matory responses, and these are less likely to be produced by
E. coli strains causing bacteriuria during pregnancy (29). A re-
cent study of a strain capable of long-term asymptomatic blad-
der colonization did not express common adhesins (type 1A
and 1C fimbriae, pyelonephritis-associated pili) and showed
limited epithelial cell adherence (13).
In this study we have characterized E. coli isolates causing
bacteriuria in pregnant woman (BU strains) by comparison
with isolates from patients with cystitis in the general popula-
tion (U strains). The study has focused on the requirement for
type 1 fimbrial expression in BU strains, including analysis of
fim switch orientation in vivo by analysis of fresh urine sam-
ples. An assay was developed to screen for the fimS49 allele,
and its frequency was determined in both of the strain sets. The
results show that the standard virulence determinants are not
as common among the strains from pregnant women (predom-
inantly asymptomatic infections) as among the strains causing
symptomatic community-acquired infections in the general
population. However, approximately one-third of BU strains
do carry the majority of virulence determinants tested for and
therefore pose a threat if left untreated. The majority of BU
strains, in contrast to the strains causing cystitis, could not
produce type 1 fimbriae. There appears to be selection against
type 1 fimbrial expression during bacteriuria of pregnancy, and
the lack of type 1 fimbrial expression may contribute to the
asymptomatic nature of the infections caused by these strains.
MATERIALS AND METHODS
Bacterial isolates. Pregnant women with significant urine cultures were invited
to attend the bacteriuria clinic. Isolates from pregnant women were obtained by
plating fresh urine samples provided at the time of the visit. Since fresh urine was
cultured, isolates were considered significant at greater than 103 CFU of E. coli
per ml of urine. The pregnant women were tested on two separate occasions.
E. coli isolates from patients with community-acquired cystitis were obtained
from specimens submitted by general practitioners and obtained from patients
admitted to the Royal Victoria Infirmary and Freeman Hospital. Isolates se-
lected from this group were present at more than 105 CFU per ml of urine. Of
these 46 patients with UTI, 85% were female. The average age was 55.9 years,
and there was no clustering of cases to single medical practices. E. coli fecal
isolates were also collected from anonymous healthy volunteers not undergoing
any antimicrobial treatment. All isolates were selected after growth on MacCo-
nkey or cystine lactose electrolyte-deficient medium agar and confirmed as E. coli
by using traditional methods, including b-glucuronidase production (26). The
following E. coli strains were included as controls for PCRs: K-12 MG1655 (type
1 fimbriae), strain 536 (10) (type 1 fimbriae, P-family, S-family, a-hemolysin), J96
(12) (type 1 fimbriae, P-family, S-family, a-hemolysin, F1C, CNF1), and AD110
(type 1 fimbriae, P-family, S-family, F1C, a-hemolysin, CNF1, and aerobactin).
All strains were stored by addition of 20% glycerol and freezing at 270°C.
DNA preparation. DNA was isolated from fresh urine cultures from the
bacteriuria clinic as follows: fresh urine (2 ml) was added to 7 ml of 8 M
guanidine hydrochloride, gently mixed, and incubated at room temperature (RT)
for over 30 min. The released DNA was bound to diatomaceous earth (1 ml of
a 10-mg/ml diatomaceous earth [Sigma-Aldrich] in 6 M guanidine hydrochlo-
ride) by gentle inversion at RT for 10 min. The DNA was then pelleted and
washed in 50% ethanol containing 200 mM sodium chloride, 10 mM EDTA, and
50 mM Tris-HCl (pH 7.4). The diatomaceous earth was pelleted by pulsed-
spinning, and the supernatant was discarded and washed as above. The pellet was
washed in acetone, recentrifuged, and then dried at 60°C for 2 min. DNA was
eluted in 100 to 500 ml of Tris-EDTA (TE) buffer by incubation at 60°C for 5 min
and then microcentrifuged. The DNA was stored with the addition of 1 ml of
chloroform as preservative.
DNA from isolates was prepared by growing the isolates overnight in defined
rich morpholinepropanesulfonic acid (MOPS) medium, and DNA was released
and purified using proteinase K and sodium perchlorate as described previously
(20).
Assaying of virulence determinants. Virulence determinant detection was
carried out by PCR using primers characterized and tested at the Institute for the
Molecular Biology of Infectious Diseases (IMBID), University of Wu¨rzburg,
Wu¨rzburg, Germany. P-family adhesin determinant detection amplifies the papF
gene using the primers 59 gtgcagattaacatcagggg-39 and 59-atgctcatactggccgtggt-39.
S-family sequence detection used primers 59-atgtctgtgcagcgggttct-39 and 59-atta
ccggcctttaccggaa-39. The primers for a-hemolysin and cytotoxic necrotizing fac-
tor (CNF) were as published (5, 19). Type 1 fimbrial expression was assayed by
testing for mannose inhibition of yeast agglutination after isolates were repeat-
edly cultured overnight (for 3 nights) in static Luria-Bertani broth. fim switch
orientation was determined by amplifying the switch region with primers 2535
and 3178 using PCR conditions of 94°C for 45s, 57°C for 45s, and 72°C for 90s
(30 cycles) and digesting the product with HinfI to give fragments of 416 and 227
bp in the phase-off orientation or 120 and 523 bp in the phase-on orientation
(20). The proportion of the population in the phase-off and phase-on states was
measured by separating the digested PCR fragments on a 4% polyacrylamide gel
and then staining with ethidium bromide. The relative fluorescence (total DNA)
in each band was measured using Bio-Rad gel documentation software and
hardware and then adjusted by the size (in base pairs) of each fragment. The
values for the two off and on fragments were averaged, and the proportion in the
phase-on state was calculated. The primers used to detect the presence of the
fimS49 allele (20) were IRLT (59 ATGATATGGACAGTTTTGG 39) and CS1
(59 CCTCATATGTTAAGGCATGC 39). PCR conditions were 94°C (5 min)
and then 30 cycles of 94°C for 45 s, 55°C for 45 s, and 72°C for 60 s, plus a final
extension at 72°C for 10 min.
Strain comparison by PFGE and RAPD. For pulsed-field gel electrophoresis
(PFGE) analysis, chromosomal DNA was prepared in agarose plugs and then
cleaved with the restriction enzyme XbaI (9). PFGE was carried out with the
CHEF DrII system (Bio-Rad, Munich, Germany) at 200 V in 0.5 M Tris-borate-
EDTA) (TBE) buffer at 12°C for 24 h with increasing pulse times from 5 to 50 s.
Lambda concatamers from Bio-Rad were used as size markers. Assistance with
PFGE was provided by G. Blum-Oehler, IMBID, University of Wu¨rzburg.
For randomly amplified polymorphic DNA (RAPD) analysis, three 10-mer
oligonucleotide primers (59 3 39), CCGAATTCCC (OPF 5), CCGATATCCC
(OPF 7), and GGGATATCGG (OPF 8) (14), were used to fingerprint the E. coli
isolates. RAPD PCR was carried out in 50-ml reaction volumes containing 20 ng
of E. coli chromosomal DNA, 1.25 mM each primer (Molecular Biology Unit,
University of Newcastle upon Tyne), 0.5 ml of Taq (Thermus aquaticus) poly-
merase and respective buffer (Boerhinger Mannheim), per 100 ml of reaction
mixture, 0.02 mM each dTTP, dGTP, dCTP, and dATP, and autoclaved Milli-
pore-filtered water. Amplification was performed in a Gene Cycler (Bio-Rad
Laboratories) programmed for an initial cycle of 94°C for 4 min and then 40
cycles of 30 s at 94°C, 1 min at 36°C, and 1 min 30 at 72°C. An extension step at
72°C for 10 min was included after the 40 cycles. Amplification products were
resolved by electrophoresis in a 1.5% agarose gel stained with ethidium bromide.
RESULTS
Comparison of the distribution of virulence determinants
among isolates from bacteriuria of pregnancy with isolates
from patients with cystitis. Isolates from the two groups were
analyzed by PCR for the presence of genes for a-hemolysin,
CNF1, aerobactin, and the fimbrial adhesins type 1, F1C, P-
family, and S-family. All control strains were positive for the
anticipated determinants (see Materials and Methods). The
distribution of these genes between the two isolate groups is
shown in Table 1. The distribution of determinants among the
cystitis strains was in agreement with previous studies (see, e.g.,
references 4 and 5), although the frequency for cnf1 was
slightly higher than that for hlyA. The carriage of genes for
adhesins, CNF1, and aerobactin was lower among the bacteri-
uria of pregnancy strains than those isolated from cystitis pa-
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tients. The majority of strains from both sets carry the type 1
fimbrial switch region. Carriage of virulence determinants was
linked in both sets of strains, especially genes for P-family
adhesins, S-family adhesins, a-hemolysin, and CNF1 (data not
shown). Of the bacteriuria of pregnancy strains, 33% (14 of 43)
carried at least four of the seven determinants tested, com-
pared with 51% (24 of 47) of the cystitis strains.
Expression of type 1 fimbriae. A major focus for this study
was the expression of type 1 fimbriae in the isolates causing
infections in the pregnant women group in comparison with
that in the strains isolated from nonpregnant individuals with
symptomatic infections. A PCR amplification used to amplify
the fim switch demonstrated the switch region to be present in
.85% of strains in both groups. Phenotypic testing revealed a
marked difference, with 32 of 42 cystitis strains (76%) testing
positive for mannose-sensitive agglutination but only 15 of 42
bacteriuria isolates from pregnant women (36%) testing posi-
tive (P , 0.01). Therefore, while all the E. coli strains isolated
from pregnant women with urinary tract infections carried the
fimS regulatory region, 64% could not produce type 1 fimbriae
in repeated overnight static culture in Luria-Bertani broth,
conditions that usually favor expression. This figure is signifi-
cantly lower than expression by strains isolated from cystitis
patients. Interestingly, 18 of 26 fecal E. coli isolates from
healthy volunteers (69%) could express type 1 fimbriae in vitro,
a proportion equivalent to that of cystitis isolates (76%), indi-
cating that the low level found in bacteriuria of pregnancy
isolates is exceptional.
Detection of the fimS49 allele by PCR. A previous analysis of
fim phase variation among urinary tract isolates identified a
specific AT base pair insertion in the fim switch region that
inhibits FimB activity on the fim switch. The activity of this
recombinase is required to turn on the expression of type 1
fimbriae. A bacterium with fimS49 is 500 times less likely to
switch on the production of type 1 fimbriae. In essence, this
means that such strains do not produce detectable type 1 fim-
briae under even favorable laboratory conditions. To deter-
mine the frequency of this allele between cystitis and bacteri-
uria of pregnancy strains, a PCR assay was developed using an
allele-specific primer with the AT base pair insertion at the 39
end (see Materials and Methods). The assay (Fig. 1) was val-
idated by sequencing a selection of positive and negative sam-
ples. Of 47 isolates from the prenatal clinic, 8 (17%) possessed
the insert, whereas only 2 of 60 isolates from patients with
community-acquired UTI (3.3%) possessed the insert (P ,
0.05). To rule out the possibility that a single clonal type con-
taining the allele was causing infections among pregnant
women being tested at the clinic, the isolates containing the
allele were analyzed by RAPD and PFGE. While two of the
eight isolates were closely related, the other six were different
by both methods (data not shown). In addition, the eight
strains differed in their possession of the other virulence de-
terminants screened for in the study. Three carried none of the
factors, two carried just aerobactin, two carried just P-family
sequences, and one carried just the F1C sequence. The fimS49
allele was therefore found in a number of different strain
backgrounds, none of which carried multiple virulence-associ-
ated determinants. This allele is capable of eliminating type 1
fimbria production and was more prevalent in the strains iso-
lated from women with bacteriuria of pregnancy than in the
cystitis-associated strains isolated from the general population.
Analysis of fim switch orientation in vivo. To determine the
fim switch orientation in vivo, infected urine from patients
visiting the prenatal clinic was collected and the bacterial DNA
was prepared immediately as described in Materials and Meth-
ods. At a later time, switch orientation was determined by PCR
and restriction enzyme analysis as described previously (20).
The orientation of the switch under these in vivo conditions
was compared with that from in vitro growth of the same
isolate in MOPS defined rich medium. The purpose of this
study was twofold: (i) to confirm that isolates containing the
extra AT allele had the fim switch in the off orientation during
infection (bacteria assayed in the urine will either be free or
attached to mucus or uroepithelial cells), and (ii) to determine
if isolates capable of producing type 1 fimbriae in vitro had
expression switched on in vivo and whether regulation differed
between the two environments. One possible problem with the
in vivo assay is that the orientation of the fim switch is sensitive
to environmental conditions, including temperature. There-
fore, to show that adding the bacteria to guanidine hydrochlo-
ride does preserve the fim switch in the original sample orien-
tation, the following experiment was carried out. The switch
orientation from a bacterial population in the process of tran-
sition from on to off (controlled by a temperature and medium
shift [6]) was determined using three sample preparation
methods: (i) immediate boiling of samples and then placing
them in 8 M guanidine hydrochloride; (ii) placing them in 8 M
TABLE 1. Analysis of E. coli isolates for possession of virulence determinants by PCR
Isolate source
No. of isolates with determinant/total no. (%)
Type 1 fimbriae P-family adhesins S-family adhesins F1C a- Hemolysin CNF1 Aerobactin
Pregnant women 43/43 (100) 13/43 (30) 11/43 (26) 8/43 (19) 12/43 (28) 11/43 (26) 17/43 (40)
Community-acquired cystitis patients 40/47 (85) 28/47 (60) 24/47 (51) 17/47 (36) 14/47 (30) 18/47 (38) 30/47 (64)
FIG. 1. Detection of the fimS49 allele by PCR. The primers de-
scribed in Materials and Methods were used to detect the presence of
the additional AT base pair in one of the recombinase binding sites
within the fim switch (inverted repeat right, on orientation). The se-
quences of the switch regions shown in the figure were obtained and
confirm the presence or absence of the allele as determined by PCR.
Lanes: M, molecular weight markers; 1, BU45; 2, BU51; 3, BU67; 4,
BU68; 5, BU81; 6, BU140; 7, BU47; 8, BU48; 9, MG1655; 10, blank.
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guanidine hydrochloride without boiling; and (iii) leaving the
samples for 3 h at room temperature. Placing samples into 8 M
guanidine hydrochloride was only slightly less effective at pre-
serving the switch state than was immediate boiling of the cells
(Fig. 2). As expected, leaving the samples at room temperature
allows the population to shift much more to the off phase. Con-
sequently, placing urine samples in 8 M guanidine hydrochloride
was selected because this could easily be performed at the clinic.
The switch orientation in vivo was determined for 23 infect-
ed urine samples in comparison to growth of the appropriate
isolate in the laboratory. Of these isolates, 17 were unable to ag-
glutinate yeast cells after static broth culture and 15 of the 17
had the switch in the off orientation after in vitro culture. The
same 15 had the switch detectable only in the off orientation in
the urine. This analysis included four isolates possessing the
fimS49 allele, and these were detectable only in the off orien-
tation both in vivo and in vitro (Fig. 3A). The remaining 6 iso-
lates from the 23 tested could produce type 1 fimbriae in vitro,
and 4 of these had the fim switch detectable in the on orien-
tation in vivo (see, e.g., Fig. 3B). Although these six isolates
represent a small sample, they indicate that isolates capable of
switching on expression in vitro generally do so in vivo, al-
though expression in vivo can be lower than, equal to, or greater
than that after growth in vitro (Fig. 3B).
DISCUSSION
It is now 40 years since the first studies delineated the nat-
ural history of ASB in pregnancy, and although interventional
strategies have been adopted which were based on these pio-
neering studies, little has been published concerning the bac-
terial factors important in such patients. Bacteriuria is a sig-
nificant problem during pregnancy because it can develop into
more severe infections that may have repercussions for the
health of the mother and unborn child. This research examined
the virulence genotypes of E. coli strains isolated from patients
with bacteriuria of pregnancy and compared them with the
genotypes of E. coli isolates from patients with cystitis in the
general population. The bacteriuria of pregnancy strains were
less likely to carry genes for S-family, P-family, and FIC ad-
hesins, CNF1, and aerobactin. The women who attended the
FIG. 2. Analysis of the fim switch orientation after treatment of
bacteria under different conditions. Samples were taken from a culture
of E. coli K-12 undergoing transition from the phase on to the phase
off orientation in MOPS rich defined medium (25). The x axis shows
the time at which samples were taken following the change in temper-
ature and medium conditions used to bring about a rapid shutdown in
type 1 fimbria expression (6). Samples were processed as described in
Materials and Methods and left for 3 h at room temperature prior to
PCR amplification and restriction digestion with HinfI. The ratio of
phase on to phase off bacteria was determined by quantitation of re-
striction digestion products using Bio-Rad gel documentation hard-
ware and software after polyacrylamide gel electrophoresis (5% TBE)
and ethidium bromide staining. Symbols: n , immediate boiling of the
bacteria; }, addition to 8 M guanidine hydrochloride (final concentra-
tion, 6M); , left at room temperature.
FIG. 3. Analysis of the fim switch orientation in vivo. Infected urine
from pregnant women was treated as described in Materials and Meth-
ods, and the orientation of the fim switch was analyzed by PCR and
restriction digestion with HinfI. (A) Analysis of strains carrying the
fimS49 allele. Switch orientation from infected urine: BU45, BU51,
BU67, and BU81 (lanes 2, 4, 6, and 8 respectively). The same strains
grown in MOPS rich defined medium are shown in lanes 1, 3, 5, and 7
respectively. Lane 10 contains a sample from a mixed-phase popula-
tion, and lane 11 contains the DNA molecular weight markers. The
switch is detectable only in the phase off orientation in the fimS49 BU
strains. (B) The same analysis of the fim switch orientation carried out
with other BU strains: BU47, BU48, BU113, BU125, BU128, BU132,
and BU139 (lanes 2, 4, 6, 8, 10, 12, and 14, respectively) from infected
urine. Lanes 1, 3, 5, 7, 9, 11, and 13 show the fim switch orientation
after the respective BU strains were cultured in MOPS rich defined
medium. Lane 15 contains the DNA molecular weight markers.
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bacteriuria of pregnancy clinic had been referred to the clinic
after being identified by routine screening of urine at prenatal
clinics, and they did not all report discomfort normally associ-
ated with UTIs. Cytotoxins and adhesins (especially P-related
fimbriae) can induce inflammatory responses and should be
present less frequently in asymptomatic infections (8, 11, 13,
29). Our data support this, showing that these genotypes occur
at a lower frequency in the bacteriuria of pregnancy strains.
Previous work by others addressing virulence-associated char-
acteristics of E. coli strains from pregnant women have reached
similar conclusions although not for all the determinants ana-
lyzed here (29).
A proportion of the isolates (33%) did carry genes for the
majority of factors examined and may pose more of a threat to
the mother and unborn child if left untreated than the other
isolates do. In fact, this number correlates well with the results
of early studies looking at the natural history of ASB during
pregnancy, in which approximately one-third of women de-
velop pyelonephritis (15, 22, 29). If it is the case that ascending
infection is confined to this group of strains, then limiting the
use of antimicrobials to the subset of patients with such strains
may be valid. Greater understanding of the bacterium-host
interaction in ASB will allow more effective targeting of inter-
ventional and preventative measures.
A principal aim was to understand the level and importance
of type 1 fimbria expression in the two sets of strains. This
included an analysis, where possible, of how many isolates
from each group (i) possessed the fim switch sequence and the
fimS49 allele, (ii) could express type 1 fimbriae in vitro, and
(iii) had the fim switch on or off in vivo. Over 85% of isolates
from both sets of strains carried genes for type 1 fimbriae. The
phenotypic analysis showed that only 36% of the bacteriuria of
pregnancy strains could actually express the adhesin under
favorable conditions, compared with 76% from the communi-
ty-acquired symptomatic infections (P , 0.01). This confirmed
that the usual adhesins (type 1, P, and S fimbriae) involved in
the establishment and persistence of UTIs were not as relevant
during bacteriuria of pregnancy, presumably due to the phys-
iological changes in pregnancy that have been reported to put
pregnant women at greater risk of developing bacteriuria (23).
The fimS49 allele inhibits wild-type FimB recombinase ac-
tivity at the fim switch and prevents effective expression of type
1 fimbriae in vitro. This allele occurred at a higher frequency
among the bacteriuria of pregnancy-associated strains than
among the cystitis-associated strains. Analysis of the fim switch
orientation in vivo of strains containing the fimS49 allele also
showed the switch to be locked off during infection. This was
also the case for the majority of other strains unable to express
type 1 fimbriae in vitro. Of six isolates analyzed that were able
to express type 1 fimbriae in vitro, four had a proportion of the
population with the fim switch in the on orientation during
infection. Two studies have analyzed the orientation of the fim
switch in vivo during a mouse model of infection (21, 30), and
one of these has also analyzed the switch orientation in vivo
from a number of patients with urinary tract infection (21).
While the majority of bacteria causing symptomatic infections
had the fim switch primarily in the off orientation in infected
urine and when cultured in vitro, this was not true of bacteria
attached to the uroepithelium in the mouse model, in which
over 30% had the fim switch in the phase on orientation (21).
Our observations support the finding that bacteria able to
produce type 1 fimbriae are likely to do so during infection.
However, a high proportion of the strains causing bacteriuria
during pregnancy cannot express type 1 fimbriae during the
infection.
The fimS49 allele will be one of several that prevent the
expression of type 1 fimbriae even though the genes are
present in the isolates. Of particular interest was the fact that
this allele was present in several different E. coli clonal groups
(analyzed by PFGE and RAPD). While it remains possible that
the fim genes could move horizontally between strains, their
presence on a pathogenicity island or on other transmissible
elements has never been documented. It is likely, therefore,
that the allele has arisen independently in each strain back-
ground by selection. The nature of the allele, an AT base
insertion within a fim recombinase binding site, would be ex-
tremely rare unless the recombination event makes it more
likely. However, l-like site-specific recombination is a well-
studied conservative process, with no such mechanism being
described. If the allele did arise rarely through recombination,
then it appears to have been successfully selected in the bac-
teriuria of pregnancy strains. Consequently, it appears to be
advantageous to these strains not to express this adhesin dur-
ing the bacteriuria, although a role for type 1 fimbriae in the
establishment of the infection remains possible.
As with P fimbriae, type 1 fimbriae are immunogenic and
can elicit an inflammatory immune response that causes
pyuria. In normal individuals with cystitis and pyelonephritis,
this response is a necessary burden associated with the abso-
lute need for such adhesins to initiate and maintain infections.
During pregnancy, anatomical and physiological changes mean
that infections can arise with afimbriate bacteria, and these are
not so easily displaced (for example, if the bladder is not
completely voided). Under these conditions, certain E. coli
isolates may persist more successfully if they do not initiate
inflammatory responses and maintain a low profile. Accord-
ingly, isolates that do initiate a strong response may be re-
moved, selecting for rare variants, such as those containing the
fimS49 allele, that do not express key antigens (such as type 1
fimbriae). The advantages of selecting for mutations in this
adhesin seem to outweigh the disadvantages in this situation.
Whether this “mutation” occurs and can be reversed as a
consequence of site-specific recombination at the fim switch
remains to be tested. Certainly phase variation has proven to
be a common theme for surface components expressed by
bacterial pathogens, and the occurrence of fimS49 may repre-
sent an example of small-scale evolution in a specific niche that
may be reversible.
ACKNOWLEDGMENTS
We are grateful to F. K. Gould, J. Perry, and M. Ford, Microbiology
Department, Freeman Hospital, for providing isolates and materials
and to G. Blum-Oehler for advice and assistance with PFGE.
The work was supported by a Career Development Research Fel-
lowship to D.L.G. from the British Medical Research Council and a
Ph.D. Studentship from the Harker Foundation (University of New-
castle upon Tyne) to S.J.K.
REFERENCES
1. Abraham, J. M., C. S. Freitag, J. R. Clements, and B. I. Eisenstein. 1985. An
invertible element of DNA controls phase variation of type 1 fimbriae of
798 GRAHAM ET AL. INFECT. IMMUN.
Escherichia coli. Proc. Natl. Acad. Sci. USA 82:5724–5727.
2. Berrington, A. W., and A. J. Bint. 1999. Diagnosis and management of
urinary tract infection in pregnancy. Rev. Med. Microbiol. 10:27–36.
3. Connell, H., W. Agace, P. Klemm, M. Schembri, S. Marild, and C. Svanborg.
1996. Type 1 fimbrial expression enhances Escherichia coli virulence for the
urinary tract. Proc. Natl. Acad. Sci. USA 93:9827–9832.
4. Donnenberg, M. S., and R. A. Welch. 1996. Virulence determinants of uro-
pathogenic Escherichia coli, p. 135–174. In H. L. T. Mobley and J. W. Warren
(ed.), Urinary tract infections: molecular pathogenesis and clinical manage-
ment. ASM Press, Washington, D.C.
5. Foxman, B., L. Zhang, K. Palin, P. Tallman, and C. F. Marrs. 1995. Bacterial
virulence characteristics of Escherichia coli isolates from first-time urinary
tract infection. J. Infect. Dis. 171:1514–1521.
6. Gally, D. L., J. A. Bogan, B. I. Eisenstein, and I. C. Blomfield. 1993. Envi-
ronmental-regulation of the fim switch controlling type 1 fimbrial phase
variation in Escherichia coli K-12—effects of temperature and media. J. Bac-
teriol. 175:6186–6193.
7. Gally, D. L., J. Leathart, and I. C. Blomfield. 1996. Interaction of fimB and
fimE with the fim switch that controls the phase variation of type 1 fimbriae
in Escherichia coli k-12. Mol. Microbiol. 21:725–738.
8. Godaly, G., B. Frendeus, A. Proudfoot, M. Svensson, P. Klemm, and C. Svan-
borg. 1998. Role of fimbriae-mediated adherence for neutrophil migration
across Escherichia coli-infected epithelial cell layers. Mol. Microbiol. 30:725–735.
9. Grothues, D., and B. Tummler. 1987. Genome analysis of Pseudomonas
aeruginosa by field inversion gel electrophoresis. FEMS Microbiol. Lett. 48:
419–422.
10. Hacker, J., S. Knapp, and W. Goebel. 1983. Spontaneous deletions and
flanking regions of the chromosomally inherited hemolysin determinant of
an Escherichia coli O6 strain. J. Bacteriol. 154:1145–1154.
11. Hedlund, M., C. Wachtler, E. Johansson, L. Hang, J. E. Somerville, R. P. Dar-
veau, and C. Svanborg. 1999. P fimbriae-dependent, lipopolysaccharide-inde-
pendent activation of epithelial cytokine responses. Mol. Microbiol. 33:693–703.
12. Hull, R. A., R. E. Gill, P. Hsu, B. H. Minshew, and S. Falkow. 1981. Con-
struction and expression of recombinant plasmids encoding type 1 or D-
mannose-resistant pili from a urinary tract infection Escherichia coli isolate.
Infect. Immun. 33:933–938.
13. Hull, R. A., D. C. Rudy, W. H. Donovan, I. E. Wieser, C. Stewart, and R. O.
Darouiche. 1999. Virulence properties of Escherichia coli 83972, a prototype
strain associated with asymptomatic bacteriuria. Infect. Immun. 67:429–432.
14. Karkkainen, U. M., J. Kauppinen, R. Ikaheimo, and M. L. Katila. 1996.
Random amplified polymorphic DNA (RAPD) analysis of Escherichia coli
strains: comparison of urinary and concomitant blood isolates or urosepsis
patients. Acta Physiol. Microbiol. Immunol. Scand. 104:437–442.
15. Kass, E. H. 1960. Bacteriuria and pyelonephritis of pregnancy. Arch. Intern.
Med. 105:194–198.
16. Kincaid-Smith, P., and M. Bullen. 1965. Bacteriuria in pregnancy. Lancet i:
395–399.
17. Klemm, P. 1986. 2 regulatory fim genes, fimB and fimE, control the phase
variation of type 1 fimbriae in Escherichia coli. EMBO J. 5:1389–1393.
18. Krogfelt, K. A., H. Bergmans, and P. Klemm. 1990. Direct evidence that the
fimH protein is the mannose-specific adhesin of Escherichia coli type 1
fimbriae. Infect. Immun. 58:1995–1998.
19. Kuhnert, P., J. Hacker, I. Muhldorfer, A. P. Burnens, J. Nicolet, and J. Frey.
1997. Detection system for Escherichia coli-specific virulence genes: absence
of virulence determinants in B and C strains. Appl. Environ. Microbiol. 63:
703–709.
20. Leathart, J. B. S., and D. L. Gally. 1998. Regulation of type 1 fimbriae
expression in uropathogenic Escherichia coli: heterogeneity of expression
through sequence changes in the fim switch region. Mol. Microbiol. 28:
371–381.
21. Lim, J. K., N. W. Gunther, H. Zhao, D. E. Johnson, S. K. Keay, and H. L. T.
Mobley. 1998. In vivo phase variation of Escherichia coli type 1 fimbrial genes
in women with urinary tract infection. Infect. Immun. 66:3303–3310.
22. Little, P. J. 1966. The incidence of urinary tract in 5000 pregnant women.
Lancet ii:925–928.
23. Lucas, M. J., and F. G. Cunningham. 1993. Urinary infection in pregnancy.
Clin. Obstet. Gynecol. 36:855–868.
24. McClain, M. S., I. C. Blomfield, and B. I. Eisenstein. 1991. Roles of fimB and
fimE in site-specific DNA inversion associated with phase variation of type 1
fimbriae in Escherichia coli. J. Bacteriol. 173:5308–5314.
25. Neidhardt, F. C., P. L. Bloch, and D. F. Smith. 1974. Culture media for
enterobacteria. J. Bacteriol. 119:736–747.
26. Pattyn, S. R., J. P. Sion, and J. Verhoeven. 1990. Evaluation of the LOGIC
system for the rapid identification of members of the family Enterobacteri-
aceae in the clinical microbiology laboratory. J. Clin. Microbiol. 28:1449–1450.
27. Schaeffer, A. J., J. S. Chmiel, J. L. Duncan, and W. S. Falkowski. 1984.
Mannose-sensitive adherence of Escherichia coli to epithelial cells from
women with recurrent urinary-tract infections. J. Urol. 131:906–910.
28. Sokurenko, E. V., H. S. Courtney, D. E. Ohman, P. Klemm, and D. L. Hasty.
1994. FimH family of type 1 fimbrial adhesins—functional heterogeneity due
to minor sequence variations among fimH genes. J. Bacteriol. 176:748–755.
29. Stenqvist, K., T. Sandberg, G. Lidinjanson, F. Orskov, I. Orskov, and C.
Svanborg-Eden. 1987. Virulence factors of Escherichia coli in urinary isolates
from pregnant women. J. Infect. Dis. 156:870–877.
30. Struve, C., and K. A. Krogfelt. 1999. In vivo detection of Escherichia coli type
1 fimbrial expression and phase variation during experimental urinary tract
infection. Microbiology 145:2683–2690.
31. Sussman, M., and D. L. Gally. 1999. The biology of cystitis: host and bac-
terial factors. Annu. Rev. Med. 50:149–158.
32. Svanborg, C., and G. Godaly. 1997. Bacterial virulence in urinary tract
infection. Infect. Dis. Clin. North Am. 11:513–529.
33. Wu, X. R., T. T. Sun, and J. J. Medina. 1996. In vitro binding of type
1-fimbriated Escherichia coli to uroplakins 1a and 1b—relation to urinary-
tract infections. Proc. Natl. Acad. Sci. USA 93:9630–9635.
Editor: V. J. DiRita
VOL. 69, 2001 E. COLI BACTERIURIA IN PREGNANCY AND TYPE 1 FIMBRIAE 799
